WuXi Biologics (Cayman) Inc 2020 SR
The report highlights WuXi Biologics' performance in 2020, focusing on its response to COVID-19 by enabling over 10 projects and achieving record-breaking timelines. The company significantly reduced its environmental footprint, with a 22% decrease in electricity intensity and a 25% decrease in greenhouse gas emission intensity. It also emphasized technological innovation through its proprietary platforms like WuXiBody and the extensive use of single-use technology, which saved an estimated 120,000 tons of water. Furthermore, the company established an ESG Committee and a Volunteer Association to strengthen governance and community engagement.
Company: WuXi Biologics (Cayman) Inc
Sector: Health Care
Country: China
Year: 2020
Type: SR
Pages: 74
WuXi Biologics (Cayman) Inc
ESG Report
The report highlights WuXi Biologics' performance in 2020, focusing on its response to COVID-19 by enabling over 10 projects and achieving record-breaking timelines. The company significantly reduced its environmental footprint, with a 22% decrease in electricity intensity and a 25% decrease in greenhouse gas emission intensity. It also emphasized technological innovation through its proprietary platforms like WuXiBody and the extensive use of single-use technology, which saved an estimated 120,000 tons of water. Furthermore, the company established an ESG Committee and a Volunteer Association to strengthen governance and community engagement.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Published
Mar 23, 2021
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Total Waste
Women in Management
Workplace Fatalities
Employees